ROYCE & ASSOCIATES LP - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 44 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$90,000
+63.6%
28,0640.0%0.00%0.0%
Q2 2022$55,000
-51.8%
28,0640.0%0.00%0.0%
Q1 2022$114,000
-62.4%
28,0640.0%0.00%
-50.0%
Q4 2021$303,000
-6.5%
28,0640.0%0.00%0.0%
Q3 2021$324,000
+17.4%
28,0640.0%0.00%0.0%
Q2 2021$276,000
-32.7%
28,0640.0%0.00%
-33.3%
Q1 2021$410,000
-31.8%
28,0640.0%0.00%
-40.0%
Q4 2020$601,000
+41.1%
28,0640.0%0.01%0.0%
Q3 2020$426,000
+18.0%
28,0640.0%0.01%
+25.0%
Q2 2020$361,00028,0640.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CHI Advisors LLC 2,746,265$12,440,5803.30%
Opaleye Management Inc. 1,401,000$6,346,5301.90%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,941,357$76,744,3471.71%
GREAT POINT PARTNERS LLC 900,000$4,077,0000.80%
DAFNA Capital Management LLC 236,873$1,073,0350.32%
Perceptive Advisors 2,280,709$10,331,6120.30%
Atlas Venture Advisors, Inc. 292,184$1,323,5940.28%
MANGROVE PARTNERS IM, LLC 805,815$3,650,3420.24%
Verition Fund Management LLC 1,938,822$8,782,8640.12%
Woodline Partners LP 1,681,913$7,619,0660.10%
View complete list of LARIMAR THERAPEUTICS INC shareholders